Literature DB >> 7753174

Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1.

Y Luo1, J Hurwitz, J Massagué.   

Abstract

Mammalian cell-cycle control by antimitogenic signals involves p21Cip1/WAF1 (refs 1-4), p27Kip1 (refs 5, 6) and p57Kip2 (refs 7, 8), a family of proteins that bind to and inhibit cyclin-dependent kinases (CDKs) required for initiation of S phase. The protein p21 also binds to the DNA polymerase delta processivity factor, proliferating-cell nuclear antigen (PCNA), and inhibits in vitro PCNA-dependent DNA replication. The CDK and PCNA inhibitory activities of p21 are shown here to be functionally independent and to reside in separate protein domains. The PCNA binding and inhibitory activities, which are not observed with p27 or p57, reside in the C-terminal domain of p21, whereas the CDK inhibitory activity resides in the conserved N-terminal domains of these proteins. When separately overexpressed in mammalian cells, the CDK and PCNA inhibitory domains prevent DNA replication, demonstrating a dual function of p21 as a cell-cycle inhibitor in vivo.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7753174     DOI: 10.1038/375159a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  133 in total

Review 1.  Functional role of p21 during the cellular response to stress.

Authors:  M Gorospe; X Wang; N J Holbrook
Journal:  Gene Expr       Date:  1999

2.  Mitochondrial regulation of cell death: mitochondria are essential for procaspase 3-p21 complex formation to resist Fas-mediated cell death.

Authors:  A Suzuki; Y Tsutomi; N Yamamoto; T Shibutani; K Akahane
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

3.  A U-rich element in the 5' untranslated region is necessary for the translation of p27 mRNA.

Authors:  S S Millard; A Vidal; M Markus; A Koff
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

4.  Functional analysis of cyclin-dependent kinase inhibitors of Arabidopsis.

Authors:  L De Veylder; T Beeckman; G T Beemster; L Krols; F Terras; I Landrieu; E van der Schueren; S Maes; M Naudts; D Inzé
Journal:  Plant Cell       Date:  2001-07       Impact factor: 11.277

Review 5.  Integration of the pRB and p53 cell cycle control pathways.

Authors:  C L Stewart; A M Soria; P A Hamel
Journal:  J Neurooncol       Date:  2001-02       Impact factor: 4.130

6.  G(1) and G(2) cell-cycle arrest following microtubule depolymerization in human breast cancer cells.

Authors:  April L Blajeski; Vy A Phan; Timothy J Kottke; Scott H Kaufmann
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

7.  A phosphorylation switch regulates the transcriptional activation of cell cycle regulator p21 by histone deacetylase inhibitors.

Authors:  Elisabeth Simboeck; Anna Sawicka; Gordin Zupkovitz; Silvia Senese; Stefan Winter; Franck Dequiedt; Egon Ogris; Luciano Di Croce; Susanna Chiocca; Christian Seiser
Journal:  J Biol Chem       Date:  2010-10-14       Impact factor: 5.157

8.  CDK inhibitors selectively diminish cell cycle controlled activation of the histone H4 gene promoter by p220NPAT and HiNF-P.

Authors:  Partha Mitra; Prachi N Ghule; Margaretha van der Deen; Ricardo Medina; Rong-Lin Xie; William F Holmes; Xin Ye; Keiichi I Nakayama; J Wade Harper; Janet L Stein; Gary S Stein; Andre J van Wijnen
Journal:  J Cell Physiol       Date:  2009-05       Impact factor: 6.384

9.  Guggulsterone inhibits tumor cell proliferation, induces S-phase arrest, and promotes apoptosis through activation of c-Jun N-terminal kinase, suppression of Akt pathway, and downregulation of antiapoptotic gene products.

Authors:  Shishir Shishodia; Gautam Sethi; Kwang Seok Ahn; Bharat B Aggarwal
Journal:  Biochem Pharmacol       Date:  2007-03-30       Impact factor: 5.858

10.  Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty.

Authors:  M W Chang; E Barr; M M Lu; K Barton; J M Leiden
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.